100% pharma tariffs hit July 31; Iran war disrupts supplies
Supply Chain Pulse — 2026-04-07
Trump's 100% tariff on patented drug imports takes effect July 31, potentially doubling costs for major pharmaceuticals at your facility. Meanwhile, escalating conflict in Iran threatens critical helium supplies needed for MRI operations and disrupts broader medical supply chains.
Quick Hits
- Henry Ford Health acquires 25-office Cornerstone Medical Group (Modern Healthcare)
- Merit Medical acquires View Point Medical through merger transaction (Medical Device Network)
- Medline recognizes manufacturing facilities with Golden Cone Safety Awards (PR Newswire)
- CMS proposes rule to eliminate fax machines, move to electronic claims (Modern Healthcare)
- Trump adjusts metal tariffs: 25% on derivative goods, 50% on pure metals (Supply Chain Dive - Healthcare)
Trump slaps 100% tariffs on patented drug imports starting July 31
The tariff will apply to several major pharmaceutical companies, with full implementation beginning in September. This could effectively double the cost of imported patented medications, forcing health systems to reassess drug formularies and budget allocations. Start reviewing your pharmaceutical spend now—generics may become even more attractive alternatives.
Source: Supply Chain Dive - Healthcare
Iran war chokes off helium supplies, threatening MRI operations
Ongoing conflict in Iran is disrupting global helium supplies critical for MRI cooling systems and other medical equipment. Healthcare facilities should assess their helium inventory levels and consider backup suppliers, as shortages could force imaging schedule reductions. This follows the same supply chain vulnerabilities we saw during earlier Middle East tensions.
Stryker restores manufacturing systems after cyberattack disruption
The medical device giant has told customers that its manufacturing systems are back online following what appears to be a cybersecurity incident. While details remain limited, this highlights ongoing vulnerability in medtech supply chains to cyber threats. Facilities should verify delivery schedules for Stryker products and review their own cybersecurity protocols.
Teva wins FDA approval for Prolia biosimilar, expanding osteoporosis options
Ponlimsi represents another biosimilar option for the $2.3 billion osteoporosis market dominated by Amgen's Prolia. This approval should create pricing pressure and provide health systems with negotiating leverage for denosumab therapy. Expect Teva to launch with significant discounts to capture market share from the reference product.
Source: Pharmaceutical Business Review
DOJ files antitrust lawsuit against New York-Presbyterian health system
The Justice Department alleges the health system unlawfully blocked insurers from offering cheaper alternatives at competing facilities, setting precedent for similar cases nationwide. This signals increased scrutiny of health system market power and exclusive contracting practices. Other large health systems should review their payer agreements for potential antitrust exposure.
Manufacturing sector expands but tariffs and war drive price concerns
The PMI showed growth for the third consecutive month, but 17 of 18 sectors reported price increases due to trade tensions and geopolitical conflicts. Healthcare supply chain managers should prepare for continued inflationary pressure across medical devices, pharmaceuticals, and commodities. Consider locking in longer-term contracts where possible.
Source: Supply Chain Dive - Healthcare
Neurocrine acquires Soleno for $2.9 billion, adding rare disease portfolio
The deal centers on Vykat XR for Prader-Willi syndrome, expanding treatment options for this rare genetic disorder. While niche, this acquisition reflects continued consolidation in specialty pharmaceuticals and potential supply chain implications for rare disease medications. Facilities treating PWS patients should monitor formulary changes.
Source: Pharmaceutical Business Review
California diesel prices surge to $7.22 per gallon amid broader fuel concerns
The 35-cent weekly jump in California's diesel costs significantly outpaces national trends, directly impacting medical supply delivery costs in the state. Health systems in California should expect higher logistics fees and consider consolidating deliveries where possible. This could also affect medical waste pickup and other diesel-dependent services.
Source: Supply Chain Dive - Healthcare
You're receiving this because you subscribed to Supply Chain Pulse, a daily brief for healthcare supply chain professionals. Unsubscribe